Item Details

Print View

Developments in the Prescription Drug Market: Oversight : Hearing Before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, Second Session, February 4, 2016

United States. Congress. House. Committee on Oversight and Government Reform
Format
Book; Government Document
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Language
English
SuDoc Number
Y 4.G 74/7:114-132
Description
iii, 213 pages : illustrations ; 24 cm
Notes
  • Shipping list no.: 2017-0339-P.
  • "Serial no. 114-132."
  • Includes bibliographical references.
Technical Details
  • Access in Virgo Classic
  • Staff View

    LEADER 02182nam a2200493 i 4500
    001 u7227609
    003 SIRSI
    005 20170809164941.0
    008 170724s2017 dcua b f000 0 eng c
    035
      
      
    a| (OCoLC)994629512
    042
      
      
    a| pcc
    043
      
      
    a| n-us---
    040
      
      
    a| SEN b| eng e| rda c| SEN d| GPO d| MvI
    049
      
      
    a| VA@@ a| VAL
    050
    1
    4
    a| KF27 b| .O94 2016u
    074
      
      
    a| 1016-A
    088
      
      
    a| Serial no. 114-132 (United States. Congress. House. Committee on Oversight and Government Reform)
    086
    0
      
    a| Y 4.G 74/7:114-132
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Oversight and Government Reform, e| author.
    245
    1
    0
    a| Developments in the prescription drug market : b| oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016.
    264
      
    1
    a| Washington : b| U.S. Government Publishing Office, c| 2017.
    264
      
    2
    a| Washington, DC : b| For sale by the Superintendent of Documents, U.S. Government Publishing Office
    300
      
      
    a| iii, 213 pages : b| illustrations ; c| 24 cm
    336
      
      
    a| text b| txt 2| rdacontent
    337
      
      
    a| unmediated b| n 2| rdamedia
    338
      
      
    a| volume b| nc 2| rdacarrier
    500
      
      
    a| Shipping list no.: 2017-0339-P.
    504
      
      
    a| Includes bibliographical references.
    500
      
      
    a| "Serial no. 114-132."
    650
      
    0
    a| Prescription pricing z| United States.
    650
      
    0
    a| Pharmaceutical industry x| Corrupt practices z| United States.
    650
      
    0
    a| Generic drugs x| Government policy z| United States.
    650
      
    0
    a| Drug approval z| United States.
    655
      
    7
    a| Legislative hearings. 2| lcgft
    776
    0
    8
    i| Online version: a| United States. Congress. House. Committee on Oversight and Government Reform. t| Developments in the prescription drug market w| (OCoLC)993261102
    596
      
      
    a| 2 17
    999
      
      
    a| Y 4.G 74/7:114-132 w| SUDOC i| X005144944 l| DOC-US m| ALDERMAN t| DOCUMENT
    999
      
      
    a| Y 4.G 74/7:114-132 w| SUDOC i| 35007100375249 l| LAW2-DOCS m| LAW t| DOCUMENT
▾See more
▴See less

Availability

Google Preview

Google Books Preview
Library Location Map Availability Call Number
Alderman US Documents (3 New) Map Available
Law 2nd Floor Documents Map Available